Synchron, Inc.

Synchron, Inc.

Synchron, Inc.

Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Founded
2016
Raised
$50M
Follow us
Alexa global traffic share
Latest funding
$40,000,000
Venture capital (Series B) - 2021
Khosla Ventures Shanda Group Subversive Capital +8
$10,000,000
Venture capital (Series A) - 2017
Defense Advanced Research Projects Agency Neurotechnology Investors (NTI)
Team Size
2
Employees
$40,000,000 Venture capital (Series B)
FinSMEs

Synchron Raises $40M in Series B Funding

$10,000,000 Venture capital (Series A)
FierceBiotech

Synchron bags $10M Series A for brain-machine interface implant